Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +52.77%
#2 Pons Pons +45.08%
#3 TENDIES TENDIES +43.57%
#4 PondCoin PondCoin +39.77%
#5 Magma Finance Magma Finance +34.63%
#6 Purr Purr +32.38%
#7 StonkBroker StonkBroker +31.36%
#8 Ocean Protocol Ocean Protocol +28.98%
#9 SkyAI SkyAI +27.20%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.14%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Muromachi Chemicals Inc. Muromachi Chemicals Inc.

Muromachi Chemicals Inc.

4885
Rang in Aktien #28995
Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals,... Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals, health foods, and chemicals in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services, including GLP analysis, storage, stability testing, and repurification of radioisotopes. The company also provides traditional tablets; jelly; and non-alcoholic beverage products. In addition, it offers ion-exchange resins; separation membranes; water-treatment products; and contract processing services. Further, it provides functional adhesives; product contamination removal and dust removal mats, and antistatic products for use in the electronics industry; and engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.
Aktienkurs
$5.83
Marktkapitalisierung
$23.48M
Veränderung (1 Tag)
-1.54%
Veränderung (1 Jahr)
14.65%
Land
JP
Handel Muromachi Chemicals Inc. (4885)

Kategorie

Healthcare
P/B-Verhältnis für Muromachi Chemicals Inc. (4885)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Muromachi Chemicals Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Muromachi Chemicals Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0911 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT